Contrarian Sales Techniques

JANUARY 30, 2023

According to the Bureau of Labor Statistics, employment of medical and pharmaceutical sales representatives is projected to grow 3 percent from 2020 to 2030, about as fast as the average for all occupations. However, the industry is becoming more competitive and navigating the industry is becoming harder.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

Pharmaceutical Technology

JULY 21, 2022

The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world. As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. Access to medication.

Government 52

Government Healthcare Healthcare Pharma 52

pharmaphorum

JANUARY 16, 2023

The bi-weekly intramuscular shot – which was also approved in China in 2021 – will enter a crowded market for long-acing injectable (LAI) schizophrenia therapies in the US and have to take on heavyweight competition, including drugs that require less frequent dosing.

FDA 52

FDA Pharma Marketing Competition 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 87

Medicine Healthcare Healthcare Pharma 87

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. from 2023 to 2030. Big data can help clinical trial design, allowing researchers to leverage genetic makeup, historical patient data, past trial results, demographics, and more to find the right participants. Poised to grow at a CAGR of 29.4%

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

MARCH 24, 2023

According to GlobalData, competition to develop a first-to-market drug for NASH is strong. This is important for a condition that requires chronic treatment, as poor GI tolerability could adversely affect patients’ quality of life, adherence to treatment and clinical outcomes. 89bio is one of several companies advancing treatments.

Medical 83

Medical Side effects Safety Pharmaceutical 83

Every Ancillary

MAY 14, 2021

According to one estimate from P&S Research , this market is expected to grow nearly 5x by 2030! Cons: Highly competitive with new options continually emerging. Pros: Make a real difference in improving patient lives. Patient compliance can be an issue. Not accessible for every patient. Opportunities: Premier.

Medical sales 52

Medical sales Medical Sales Insurance 52

Pharmaceutical Technology

NOVEMBER 23, 2022

Lifted by increased interest after the onset of the Covid-19 pandemic, the sector is expected to balloon to US$853 billion by 2030. The combined CCRM and OmniaBio team is a model for adopting new cutting-edge technologies and making these available to our clinical and commercial clients, ultimately reaching patients in need around the world.

Marketing 52

Marketing Manufacturing Transportation Government 52

pharmaphorum

NOVEMBER 10, 2022

Having noted that by 2035 it is predicted that there will be a 24% increase in cancer diagnoses, Arlukwiez, BECA’s chair, stressed within his recorded apology message that the patient is the guiding principle and that there must be equality of treatment across the EU. Excellence in cancer care is not just survivorship, but patient outcome.

Electronics 77

Electronics Government Patients Pharma 77

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. The device replaces a connecting bone in the ankle joint and can be customized according to patient preference. Still, that’s just an estimation.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

pharmaphorum

JANUARY 4, 2023

The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. Rights for individuals.

Pharmaceutical 85

Pharmaceutical Electronics Healthcare Healthcare 85

Spotio

FEBRUARY 9, 2023

Furthermore, the organization predicts it will outpace the GDP by 2030. Increased competition Your sales team also faces more competition than ever before. This method won’t cut it in years to come if you expect to separate yourself from the competition. Focus on the patient benefits Doctors care for patients.

Sales 52

Sales Medical Doctors Sales process 52

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. The device replaces a connecting bone in the ankle joint and can be customized according to patient preference. Still, that’s just an estimation.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

PM360

AUGUST 9, 2022

Science continues to evolve rapidly, most recently delivering more complex technologies with the advent of immunotherapies, cell and gene therapies, and more platform technologies (such as CRISPR) that target diseases with niche patient subgroups. Ask: Is this component truly a competitive advantage? The Payoff Is Real.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones. References: Elverum K, Whitman M.

Manufacturing 74

Manufacturing Pharmaceutical Healthcare Healthcare 74

Healthcare Success

NOVEMBER 14, 2022

billion in 2030 ). The Patient Protection and Affordable Care Act of 2010 has increased access to healthcare services for previously uninsured populations. Differentiating medical devices can be challenging due to commoditization and the fast pace of technological advances, but it’s critical to stand out in a competitive device market.

Medical 65

Medical Marketing Engineering Doctors 65

Pharmaceutical Technology

JANUARY 11, 2023

How patients receive treatment is being revolutionised by advancements in AI and machine learning, the internet of things (IoT) and extended reality, coupled with a growing comfort with digital devices including smartphones and telehealth, as a part of managing one’s care. The global market size is estimated to be more than $95.3bn 1.

Healthcare 52

Healthcare Healthcare Medical Electronics 52

Pharmaceutical Technology

JUNE 15, 2023

Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars.

Education 52

Education Patients Healthcare Healthcare 52

Pharmaceutical Technology

JUNE 19, 2023

A Rosemont spokesperson affirmed the company’s enthusiasm for the market, telling Pharmaceutical Technology that single-use sachets offer a greater level of convenience for current and potential patients. These offerings will complement over 130 oral liquid medicines currently offered by Rosemont to meet the needs of dysphagic patients.

Medicine 52

Medicine Manufacturing Marketing Pharmaceutical 52

Clarivate

DECEMBER 14, 2023

However, the PBM-focused strategy can result in higher out-of-pocket costs for patients who pay coinsurance for drugs based on WAC prices and may spur further criticism. Payers will continue to take ownership of providers, with numerous Blue plans staking a claim to settings where they can funnel patients to lower-cost care.

Marketing 52

Marketing Healthcare Healthcare Insurance 52